Inflammatory signaling in targeted therapy resistance: focus on EGFR-targeted treatment

被引：0
|
作者：
Luo, Zhihong [1 ]
Gong, Ke [1 ]
机构：
[1] Wuhan Univ, Taikang Ctr Life & Med Sci, Taikang Med Sch, Sch Basic Med Sci,Hubei Prov Key Lab Allergy & Imm, Wuhan 430071, Peoples R China
来源：
CANCER BIOLOGY & MEDICINE | 2024年 / 21卷 / 10期
基金：
美国国家科学基金会; 中国国家自然科学基金;
关键词：
BRAF; INHIBITION;
D O I：
10.20892/j.issn.2095-3941.2024.0327
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：831 / 837
页数：7
相关论文
共 50 条
  • [1] Inflammatory signaling in targeted therapy resistance: focus on EGFR-targeted treatment
    Zhihong Luo
    Ke Gong
    Cancer Biology & Medicine, 2024, 21 (10) : 831 - 837
  • [2] EGFR-TARGETED THERAPY AND RESISTANCE
    Hasovits, Csilla
    Pavlakis, Nick
    CANCER FORUM, 2013, 37 (02) : 165 - 169
  • [3] EGFR-targeted therapy
    Vecchione, Loredana
    Jacob, Bart
    Normanno, Nicola
    Ciardiello, Fortunato
    Tejpar, Sabine
    EXPERIMENTAL CELL RESEARCH, 2011, 317 (19) : 2765 - 2771
  • [4] Resistance to EGFR-Targeted Therapy: A Family Affair
    Vlacich, Gregory
    Coffey, Robert J.
    CANCER CELL, 2011, 20 (04) : 423 - 425
  • [5] Adaptive Resistance to EGFR-Targeted Therapy by Calcium Signaling in NSCLC Cells
    Mulder, Celine
    Prust, Nadine
    van Doorn, Sander
    Reinecke, Maria
    Kuster, Bernhard
    Henegouwen, Paul van Bergen En
    Lemeer, Simone
    MOLECULAR CANCER RESEARCH, 2018, 16 (11) : 1773 - 1784
  • [6] EGFR-Targeted Photodynamic Therapy
    Ulfo, Luca
    Costantini, Paolo Emidio
    Di Giosia, Matteo
    Danielli, Alberto
    Calvaresi, Matteo
    PHARMACEUTICS, 2022, 14 (02)
  • [7] EGFR-Targeted Therapeutics: Focus on SCCHN and NSCLC
    Sattler, Martin
    Abidoye, Oyewale
    Salgia, Ravi
    THESCIENTIFICWORLDJOURNAL, 2008, 8 : 909 - 919
  • [8] Resistance to EGFR-targeted therapy by Ets-1 inactivation
    Tetsu, Osamu
    Eisele, David W.
    McCormick, Frank
    CELL CYCLE, 2015, 14 (20) : 3211 - 3212
  • [9] Current perspectives in EGFR-targeted therapy
    不详
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2019, 12 : S32 - S34
  • [10] Overcoming resistance to EGFR-targeted therapies in cancer
    Laffman-Johnson, Elise
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 (02) : 120 - 120
12345